Chemed Corp: Form 10-Q for the period ended Sep 30, 2011
Filed with the SEC on Nov 4, 2011 and accepted by EDGAR at Nov 4, 2011, 13:16 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2011-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2011-07-01 to 2011-09-30 | $341.4m | us-gaap:SalesRevenueNet |
| Revenue | 9 months2011-01-01 to 2011-09-30 | $1.01bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2011-07-01 to 2011-09-30 | $245.1m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2011-01-01 to 2011-09-30 | $722.1m | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months2011-07-01 to 2011-09-30 | $47.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2011-01-01 to 2011-09-30 | $153.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2011-07-01 to 2011-09-30 | $41.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2011-01-01 to 2011-09-30 | $107.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2011-07-01 to 2011-09-30 | $3.6m | us-gaap:InterestExpense |
| Interest expense | 9 months2011-01-01 to 2011-09-30 | $10.3m | us-gaap:InterestExpense |
| Income tax | 3 months2011-07-01 to 2011-09-30 | $13.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2011-01-01 to 2011-09-30 | $38.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2011-07-01 to 2011-09-30 | $21.9m | us-gaap:NetIncomeLoss |
| Net income | 9 months2011-01-01 to 2011-09-30 | $60.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2011-07-01 to 2011-09-30 | $1.04 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2011-01-01 to 2011-09-30 | $2.82 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2011-07-01 to 2011-09-30 | $1.06 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2011-01-01 to 2011-09-30 | $2.88 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2011-07-01 to 2011-09-30 | 21,055,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2011-01-01 to 2011-09-30 | 21,400,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2011-01-01 to 2011-09-30 | $107.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2011-01-01 to 2011-09-30 | $23.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2011-01-01 to 2011-09-30 | $9.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2011-01-01 to 2011-09-30 | $110.3m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2011-09-30 | $21.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2011-09-30 | $168.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2011-09-30 | $815.1m | us-gaap:Assets |
| Current liabilities | At period end2011-09-30 | $160.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2011-09-30 | $388.7m | us-gaap:Liabilities |
| Long-term debt | At period end2011-09-30 | $164.8m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2011-09-30 | $426.3m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2011-09-30 | 19,881,497 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001157523-11-006471. Last ingested by Listed: Nov 14, 2026, 12:29 ET. Listed shows no prices and gives no investment advice.